• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心内膜炎的管理:阿根廷的门诊胃肠外抗生素治疗

Management of endocarditis: outpatient parenteral antibiotic treatment in Argentina.

作者信息

Lopardo G

机构信息

Fundación Centro de Estudios Infectológicos (FUNCEI), Buenos Aires, Argentina.

出版信息

Chemotherapy. 2001;47 Suppl 1:24-32. doi: 10.1159/000048565.

DOI:10.1159/000048565
PMID:11096186
Abstract

Patients with infective endocarditis often face lengthy hospitalization for parenteral antibiotic therapy. Efforts to reduce medical costs have led to consideration of outpatient parenteral antibiotic treatment (OPAT) for these patients. However, concerns about outpatient management of complications, particularly congestive heart failure and emboli, exist. In Argentina, carefully selected patients with infective endocarditis, representing a low-risk population, have been successfully treated with OPAT. A retrospective analysis was conducted of 48 such patients. Three delivery models were used: at home with medications given by the visiting nurse, at infusion center, or at home with medications self-administered. Ten patients received OPAT only; 38 were initially hospitalized, then transferred to an OPAT program. Twenty-nine patients had streptococcal disease, 37 out of 48 patients were treated with ceftriaxone. Clinical and microbiologic cure was achieved in all patients. Three patients developed heart failure, 2 prior to starting antibiotic therapy. Four developed emboli, all prior to starting antibiotics. Surgery was required in 5 patients: 2 were treated with OPAT postoperatively and 3 had surgery after antibiotic therapy was completed. OPAT for infective endocarditis is safe in well selected patients.

摘要

感染性心内膜炎患者通常需要长时间住院接受胃肠外抗生素治疗。降低医疗成本的努力促使人们考虑对这些患者进行门诊胃肠外抗生素治疗(OPAT)。然而,对于门诊并发症管理,尤其是充血性心力衰竭和栓塞,仍存在担忧。在阿根廷,经过精心挑选的感染性心内膜炎患者,属于低风险人群,已成功接受OPAT治疗。对48例此类患者进行了回顾性分析。采用了三种给药模式:在家由访视护士给药、在输液中心给药或在家自行给药。10例患者仅接受OPAT治疗;38例最初住院,然后转入OPAT项目。29例患者患有链球菌疾病,48例患者中有37例接受头孢曲松治疗。所有患者均实现临床和微生物学治愈。3例患者出现心力衰竭,2例在开始抗生素治疗前出现。4例发生栓塞,均在开始抗生素治疗前出现。5例患者需要手术:2例术后接受OPAT治疗,3例在抗生素治疗完成后进行手术。对于精心挑选的患者,感染性心内膜炎的OPAT治疗是安全的。

相似文献

1
Management of endocarditis: outpatient parenteral antibiotic treatment in Argentina.心内膜炎的管理:阿根廷的门诊胃肠外抗生素治疗
Chemotherapy. 2001;47 Suppl 1:24-32. doi: 10.1159/000048565.
2
Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.门诊静脉用抗生素治疗感染性心内膜炎的疗效和安全性:一项十年前瞻性研究。
Enferm Infecc Microbiol Clin. 2011 Oct;29(8):587-92. doi: 10.1016/j.eimc.2011.05.007. Epub 2011 Jun 30.
3
The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries.门诊胃肠外抗菌治疗在骨髓炎管理中的应用:来自门诊胃肠外抗菌治疗结果登记处的数据
Chemotherapy. 2001;47 Suppl 1:5-16. doi: 10.1159/000048563.
4
Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy.门诊患者感染性心内膜炎的管理:门诊胃肠外抗生素治疗的临床经验
South Med J. 2009 Jun;102(6):575-9. doi: 10.1097/SMJ.0b013e3181a4eef2.
5
Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.感染性心内膜炎的自我管理门诊胃肠外抗菌治疗(S-OPAT):一种安全有效的模式。
Eur J Intern Med. 2015 Mar;26(2):131-6. doi: 10.1016/j.ejim.2015.01.001. Epub 2015 Jan 14.
6
Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.英国某中心 4 年经验回顾:感染性心内膜炎的门诊患者肠外抗生素治疗。
Postgrad Med J. 2012 Jul;88(1041):377-81. doi: 10.1136/postgradmedj-2011-130355. Epub 2012 Feb 25.
7
Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.粪肠球菌感染性心内膜炎的门诊胃肠外抗菌治疗
J Clin Pharm Ther. 2018 Apr;43(2):220-223. doi: 10.1111/jcpt.12635. Epub 2017 Oct 13.
8
Safety and clinical outcomes of outpatient parenteral antibiotic therapy for infective endocarditis in Christchurch, New Zealand: A retrospective cohort study.新西兰克赖斯特彻奇市门诊静脉注射抗生素治疗感染性心内膜炎的安全性和临床结局:一项回顾性队列研究。
Int J Infect Dis. 2023 Sep;134:172-176. doi: 10.1016/j.ijid.2023.06.008. Epub 2023 Jun 16.
9
Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.基于居家医院计划缩短住院时间背景下,自我管理的门诊肠外抗菌药物治疗(s-opat)用于感染性心内膜炎的疗效。
Hosp Pract (1995). 2017 Dec;45(5):246-252. doi: 10.1080/21548331.2017.1398588. Epub 2017 Nov 10.
10
Outpatient treatment of endocarditis in a clinic-based program in Argentina.阿根廷一项基于诊所的项目中的心内膜炎门诊治疗。
Eur J Clin Microbiol Infect Dis. 1995 Jul;14(7):648-54. doi: 10.1007/BF01690747.

引用本文的文献

1
Safety and Efficacy of Outpatient Parenteral Antibiotic Therapy (OPAT) in Patients With Infective Endocarditis: A Systematic Review and Meta-Analysis.门诊肠外抗生素治疗(OPAT)用于感染性心内膜炎患者的安全性和有效性:一项系统评价和荟萃分析
Clin Cardiol. 2025 May;48(5):e70147. doi: 10.1002/clc.70147.
2
Factors associated with successful completion of outpatient parenteral antibiotic therapy in an area with a high prevalence of multidrug-resistant bacteria: 30-day hospital admission and mortality rates.多药耐药菌高发地区门诊肠外抗生素治疗成功完成的相关因素:30 天住院率和死亡率。
PLoS One. 2020 Nov 18;15(11):e0241595. doi: 10.1371/journal.pone.0241595. eCollection 2020.
3
Clinical and cost-effectiveness, safety and acceptability of ommunity ntraenous ntibiotic ervice models: CIVAS systematic review.
社区静脉抗生素服务模式的临床及成本效益、安全性与可接受性:CIVAS系统评价
BMJ Open. 2017 Apr 20;7(4):e013560. doi: 10.1136/bmjopen-2016-013560.